difference between dulaglutide and semaglutide Dosing Patterns of in Patients with Type 2 Diabetes Mellitus in France and Italy: A Retrospective Cohort Study | Advances in Therapy what is the difference between

Sci Adv 5:eaaw2238 Hao X, Shao Z, Zhang N, Jiang M, Cao X, Li S et al (2023) Integrative genome-wide analyses identify novel loci associated with kidney stones and provide insights into its genetic architecture

UK product information advises that patients should: Recognise symptoms of pancreatitis (severe, persistent abdominal pain radiating to the back, nausea, vomiting) Seek immediate medical attention if these symptoms develop Discontinue the medicine if pancreatitis is suspected Not restart the GLP-1 medicine if pancreatitis is confirmed Patients should also be aware of an increased risk of gallbladder disease (gallstones, cholecystitis) with GLP-1 medicines, which can present with similar abdominal symptoms and requires prompt medical attention

found that ASCT2 ligands chloroalanine, aminooxetane-3-carboxylate (AOC), and -FBP also inhibit ASCT2-mediated glutamine uptake in human melanoma cells [104]

2023, doi: 10.1007/s12630-023-02549-5